MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2022-23)
- Udyam number
- UDYAM-MH-33-0206526
Tawwab Pharma Private Limited - pharma in Thane, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹8.58 Cr
▲ 3% YoY
Net profit · FY 2024
₹26.57 Lakh
Net margin 3.1%
EBITDA · FY 2024
₹44.07 Lakh
EBITDA margin 5.1%
Authorised capital
₹47.9 Lakh
Registered with MCA
Paid-up capital
₹33.51 Lakh
Issued & subscribed
Open charges
₹90 Lakh
Satisfied ₹51 Lakh
Company age
8 yrs
Est. 2018
Directors on board
2
As per MCA filings
About Tawwab Pharma Private Limited
Data last updated:
Tawwab Pharma Private Limited is a private limited company based in Thane, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 25 July 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74999MH2018PTC312223. Its GSTIN is 27AAGCT8666A1Z5 (Maharashtra).
The company has an authorised share capital of ₹47.9 Lakh and a paid-up capital of ₹33.51 Lakh. It is led by directors Mehjabeen Irfan Kazi and Irfan Gaffar Kazi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Thane, Maharashtra.
As per the financials filed for FY 2024, the company reported a revenue of ₹8.58 Cr, a growth of 3% compared to the previous year. For the same year it recorded a net profit of ₹26.57 Lakh (net margin 3.1%) and EBITDA of ₹44.07 Lakh (EBITDA margin 5.1%). Revenue has grown at a compounded annual rate (CAGR) of 50% over three years and 525% over five years.
The company is associated with 1 brand: Tawwab Pharma. As per MCA filings, the company has open charges of ₹90 Lakh and satisfied charges of ₹51 Lakh on record. The company has 2 deals on record (2 funding rounds), with disclosed funding of ₹44.5 Lakh; the latest was in March 2022. Its 10 peer companies in the same principal business activity (wholesale trading) are compared by revenue, 5 larger and 5 smaller; the largest is Biomed (I) Healthcare Private Limited with revenue of ₹8.58 Cr.
Tawwab Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-33-0206526). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website tawwabpharma.com.
Company details
CIN U74999MH2018PTC312223
Registration Number 312223
Incorporation Date 25 July 2018
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-MH-33-0206526
Recognitions & Rankings of Tawwab Pharma
Contact details
Tawwab Pharma Private Limited's registered office is in Thane, Maharashtra. Its website is tawwabpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressF – 11 Plot No – 88/91, Sect – 19A Nerul, Thane, Maharashtra, India – 400706
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Tawwab Pharma Private Limited, buy the company report.
Comprehensive company report
Tawwab Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Tawwab Pharma operates one associated brand: Tawwab Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical manufacturing and supply of drugs, supplements, and healthcare solutions in India. | tawwabpharma.com |
Business activity
The main business activity of Tawwab Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Tawwab Pharma Private Limited, buy the company report.
Financials of Tawwab Pharma Private Limited
FY 2025 filings availableTawwab Pharma Private Limited reported revenue of ₹8.58 Cr (up 3% YoY) for FY 2024.
Revenue · FY 2024
₹8.58 Cr ▲ 3%
Net profit · FY 2024
₹26.57 Lakh margin 3.1%
EBITDA · FY 2024
₹44.07 Lakh margin 5.1%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 3%
3 years · compounded
▲ 50%
5 years · compounded
▲ 525%
EBITDA CAGR growth
1 year
▼ 30%
3 years · compounded
▲ 51%
5 years · compounded
▲ 515%
Revenue has grown at a compounded annual rate (CAGR) of 525% over five years, including 3% growth in the latest year. EBITDA fell 30% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹44.07 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹26.57 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.1% | ||||
| Net Profit Margin | 3.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Tawwab Pharma Private Limited, buy the company report.
Board of directors of Tawwab Pharma Private Limited
Tawwab Pharma has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mehjabeen Irfan Kazi Also directs: Imia Healthcare Private Limited | Director | 25 Jul 2018 | 8 Years 3 Months | Current |
| Irfan Gaffar Kazi Also directs: Imia Healthcare Private Limited | Director | 25 Jul 2018 | 8 Years 3 Months | Current |
Peer comparison
Tawwab Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Biomed (I) Healthcare Private Limited | ₹8.58 Cr (FY 2019) | -4.0% | Hyderabad, Telangana, India | |||
| Ky Smart Gold Private Limited | ₹8.58 Cr (FY 2025) | -2.0% | Surat, Gujarat, India | |||
| Modasa Pharmaceuticals Private Limited | ₹8.58 Cr (FY 2025) | 37.0% | Modasa, Gujarat, India | |||
| Shree Matre Trading Private Limited | ₹8.58 Cr (FY 2025) | 613.0% | Hyderabad, Telangana, India | |||
| Wcube Solutions Private Limited | ₹8.58 Cr (FY 2022) | 464.0% | New Delhi, Delhi, India | |||
| Tawwab Pharma Private Limitedthis company | ₹8.58 Cr (FY 2024) | ₹26.57 Lakh | 3.1% | 3.0% | Thane, Maharashtra, India | |
| Reloved Gadgets Private Limited | ₹8.58 Cr (FY 2025) | -20.0% | New Delhi, Delhi, India | |||
| Fronteria Systems Private Limited | ₹8.57 Cr (FY 2021) | 309.0% | Mumbai, Maharashtra, India | |||
| Susri Computers and Consultancy Private Limited | ₹8.57 Cr (FY 2025) | -28.0% | Khurda, Odisha, India | |||
| Gagan Impex Private Limited | ₹8.57 Cr (FY 2025) | -46.0% | Vijayawada, Andhra Pradesh, India | |||
| Mantan Retail Private Limited | ₹8.57 Cr (FY 2024) | -3.0% | Delhi, India |
To see the full peer comparison of Tawwab Pharma Private Limited, buy the company report.
Auditor
Tawwab Pharma Private Limited is audited by HARISH CHOUDHARY & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| HARISH CHOUDHARY & ASSOCIATES | FY 2023 | 137444W |
Shareholding
The shareholding of Tawwab Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Tawwab Pharma Private Limited, buy the company report.
Charges & borrowings
Open charges
₹90 Lakh
Satisfied charges
₹51 Lakh
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 24 Aug 2024 | 100982527 | Others | ₹90 Lakh | Open | |
| 07 Jul 2022 | 100607919 | State Bank of India | ₹51 Lakh | Satisfied |
To see the full charge records of Tawwab Pharma Private Limited, buy the company report.
Total charge records: 2 View all charges
Deals & funding
Tawwab Pharma Private Limited has 2 deals on record (2 funding rounds), with disclosed funding of ₹44.5 Lakh; the latest was in March 2022.
Total deals
2
Funding rounds
2
Disclosed funding
₹44.5 Lakh
Deals on record (2 of 2)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2022 | Funding round | ₹22.9 Lakh | Investors: an individual |
| Mar 2020 | Funding round | ₹21.6 Lakh | Investors: an individual |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Tawwab Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Tawwab Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Tawwab Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAGCT8666A1Z5 | Maharashtra | Active | 22 Feb 2019 |
To see the full GST registrations and return filing status of Tawwab Pharma Private Limited, buy the company report.
Recent activity
Tawwab Pharma Private Limited has 2 board changes on record since 2018: 2 appointments. The latest: Irfan Gaffar Kazi was appointed as Director on 25 Jul 2018.
AGM
Tawwab Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Tawwab Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Charges
A charge with Others of Rs. 90.00 Lakh registered on 24 Aug 2024 with Charge ID 100982527 was modified on 22 Mar 2025.
Charges
A charge registered on 07 Jul 2022 via Charge ID 100607919 with State Bank Of India was fully satisfied on 29 Nov 2024.
Charges
A charge with Others amounted to Rs. 90.00 Lakh with Charge ID 100982527 was registered on 24 Aug 2024.
Charges
A charge with State Bank Of India amounted to Rs. 51.00 Lakh with Charge ID 100607919 was registered on 07 Jul 2022.
Appointed
Irfan Gaffar Kazi was appointed as Director.
Appointed
Mehjabeen Irfan Kazi was appointed as Director.
Incorporation
25 Jul 2018
Tawwab Pharma Private Limited was registered on 25 Jul 2018 with Roc Mumbai & aged 8 years 3 months as per MCA records.
Frequently asked questions
Tawwab Pharma is an active private limited company based in Thane, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 25 July 2018 (8+ years old) and is registered under CIN U74999MH2018PTC312223.
Tawwab Pharma has 2 current directors:
- Mehjabeen Irfan Kazi - Director
- Irfan Gaffar Kazi - Director
The latest financial statements of Tawwab Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Tawwab Pharma is 27AAGCT8666A1Z5, registered in Maharashtra.
The CIN (Corporate Identification Number) of Tawwab Pharma is U74999MH2018PTC312223. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Tawwab Pharma was incorporated on 25 July 2018, making it 8+ years old. It is registered with the Registrar of Companies, Mumbai.
Tawwab Pharma has 2 deals on record (2 funding rounds), with disclosed funding of ₹44.5 Lakh; the latest was in March 2022.
The peers of Tawwab Pharma by revenue are Biomed (I) Healthcare Private Limited, Ky Smart Gold Private Limited, Modasa Pharmaceuticals Private Limited, Shree Matre Trading Private Limited, Wcube Solutions Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Irfan Gaffar Kazi was appointed as Director on 25 Jul 2018. Mehjabeen Irfan Kazi was appointed as Director on 25 Jul 2018.
Yes, Tawwab Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-33-0206526).
Tawwab Pharma can be reached through the website tawwabpharma.com. Its registered office is in Thane, Maharashtra, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages